These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 15928908)

  • 1. Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region.
    Pasquau F; Ena J; Sanchez R; Cuadrado JM; Amador C; Flores J; Benito C; Redondo C; Lacruz J; Abril V; Onofre J;
    Eur J Clin Microbiol Infect Dis; 2005 Jun; 24(6):411-8. PubMed ID: 15928908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study.
    Pintado V; Martín-Rabadán P; Rivera ML; Moreno S; Bouza E
    Medicine (Baltimore); 2001 Jan; 80(1):54-73. PubMed ID: 11204503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
    Medrano FJ; Hernández-Quero J; Jiménez E; Pineda JA; Rivero A; Sánchez-Quijano A; Velez ID; Viciana P; Castillo R; Reyes MJ
    AIDS; 1992 Dec; 6(12):1499-503. PubMed ID: 1362880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediterranean leishmaniasis in HIV-infected patients: epidemiological, clinical, and diagnostic features of 22 cases.
    Agostoni C; Dorigoni N; Malfitano A; Caggese L; Marchetti G; Corona S; Gatti S; Scaglia M
    Infection; 1998; 26(2):93-9. PubMed ID: 9561378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Visceral leishmaniasis in patients with HIV infection].
    Ribera E; Cucurull E; Ocaña I; Vallespí T; Gasser I; Juste C
    Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):73-9. PubMed ID: 7711130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain.
    Pineda JA; Gallardo JA; Macías J; Delgado J; Regordán C; Morillas F; Relimpio F; Martín-Sánchez J; Sánchez-Quijano A; Leal M; Lissen E
    J Clin Microbiol; 1998 Sep; 36(9):2419-22. PubMed ID: 9705366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
    ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
    Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical and evolutional characteristics of visceral leishmaniasis in patients with HIV infection].
    Delgado Fernández M; García Ordoñez MA; Martos Pérez F; Reguera Iglesias JM; Jiménez Oñate F; Colmenero Castillo JD
    An Med Interna; 1997 Oct; 14(10):506-10. PubMed ID: 9424140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring prognosis in chronic relapsing visceral leishmaniasis among HIV-infected patients: Circulating Leishmania DNA.
    Cota GF; de Sousa MR; de Assis TSM; Pinto BF; Rabello A
    Acta Trop; 2017 Aug; 172():186-191. PubMed ID: 28501450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil.
    Daher EF; Fonseca PP; Gerhard ES; Leitão TM; Silva Júnior GB
    J Parasitol; 2009 Jun; 95(3):652-5. PubMed ID: 19642802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral leishmaniasis (Kala-azar) in two patients with HIV-1 infection: atypical features and response to therapy.
    Hamour AA; Skelly R; Jowitt SN; Wilson GE; Curry A; Wilkins EG; Mandal BK
    J Infect; 1998 Mar; 36(2):217-20. PubMed ID: 9570658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy.
    Casado JL; Lopez-Velez R; Pintado V; Quereda C; Antela A; Moreno S
    Eur J Clin Microbiol Infect Dis; 2001 Mar; 20(3):202-5. PubMed ID: 11347673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain.
    Montalban C; Martinez-Fernandez R; Calleja JL; Garcia-Diaz JD; Rubio R; Dronda F; Moreno S; Yebra M; Barros C; Cobo J
    Rev Infect Dis; 1989; 11(4):655-60. PubMed ID: 2672242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study.
    Diro E; Ritmeijer K; Boelaert M; Alves F; Mohammed R; Abongomera C; Ravinetto R; De Crop M; Fikre H; Adera C; Colebunders R; van Loen H; Menten J; Lynen L; Hailu A; van Griensven J
    PLoS Negl Trop Dis; 2015; 9(10):e0004087. PubMed ID: 26431253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
    Ali A
    Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections.
    Russo R; Laguna F; López-Vélez R; Medrano FJ; Rosenthal E; Cacopardo B; Nigro L
    Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():99-105. PubMed ID: 14678637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV).
    Berenguer J; Moreno S; Cercenado E; Bernaldo de Quirós JC; García de la Fuente A; Bouza E
    Ann Intern Med; 1989 Jul; 111(2):129-32. PubMed ID: 2742248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Visceral leishmaniasis in immunocompromised patients].
    Ramos A; Portero JL; Gazapo T; Yebra M; Portero F; Martín T
    An Med Interna; 1998 Jun; 15(6):301-4. PubMed ID: 9656509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review.
    Cota GF; de Sousa MR; Rabello A
    PLoS Negl Trop Dis; 2011 Jun; 5(6):e1153. PubMed ID: 21666786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.